BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20664449)

  • 1. Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin.
    David AL; Ataullah I; Yates R; Sullivan I; Charles P; Williams D
    Obstet Gynecol; 2010 Aug; 116 Suppl 2():543-547. PubMed ID: 20664449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin.
    Brucato A; Ramoni V; Gerosa M; Pisoni MP
    Obstet Gynecol; 2011 Jan; 117(1):177. PubMed ID: 21173668
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
    Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
    J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal treatment of congenital heart block ascribed to anti-SSA antibody: case reports with observation of cardiohemodynamics and review of the literature.
    Yamada H; Kato EH; Ebina Y; Moriwaki M; Yamamoto R; Furuta I; Fujimoto S
    Am J Reprod Immunol; 1999 Oct; 42(4):226-32. PubMed ID: 10580604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies.
    Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA
    Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of recurrent congenital heart block in a SSA/SSB positive mother using high dose maternal IVIG from 16-week gestation.
    Sterling RA; Carlin A
    Prenat Diagn; 2015 Nov; 35(11):1148-50. PubMed ID: 26179183
    [No Abstract]   [Full Text] [Related]  

  • 8. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal lupus: bedside to bench and back.
    Buyon JP
    Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital complete heart block and maternal anti-Ro.
    Maclennan AC
    Br J Hosp Med; 1990 Jul; 44(1):61. PubMed ID: 2397339
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of maternal subclinical Sjögren's syndrome associated with congenital heart block.
    Imai F; Suzuki T; Katagiri T; Ohno S; Tanaka M; Dohi Y
    Jpn J Med; 1991; 30(1):39-42. PubMed ID: 1865576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Makino S; Yonemoto H; Itoh S; Takeda S
    Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete heart block in a fetus associated with maternal Sjögren's syndrome.
    Veille JC; Sunderland C; Bennett RM
    Am J Obstet Gynecol; 1985 Mar; 151(5):660-1. PubMed ID: 3872074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.
    Pisoni CN; Brucato A; Ruffatti A; Espinosa G; Cervera R; Belmonte-Serrano M; Sánchez-Román J; García-Hernández FG; Tincani A; Bertero MT; Doria A; Hughes GR; Khamashta MA
    Arthritis Rheum; 2010 Apr; 62(4):1147-52. PubMed ID: 20131278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal congenital complete heart block: prophylaxis with intravenous gammaglobulin and treatment with dexamethasone.
    Wong JP; Kwek KY; Tan JY; Yeo GS
    Aust N Z J Obstet Gynaecol; 2001 Aug; 41(3):339-41. PubMed ID: 11592556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen.
    Tran HB; Cavill D; Buyon JP; Gordon TP
    Arthritis Rheum; 2004 Jan; 50(1):337-8; author reply 338. PubMed ID: 14730639
    [No Abstract]   [Full Text] [Related]  

  • 17. An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease.
    Cuneo BF; Strasburger JF; Niksch A; Ovadia M; Wakai RT
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):233-8. PubMed ID: 19330707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent congenital heart block in neonatal lupus.
    Escobar MC; Gómez-Puerta JA; Albert D; Ferrer Q; Girona J
    Clin Rheumatol; 2007 Jul; 26(7):1161-3. PubMed ID: 16586043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital heart block: successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapy.
    Kaaja R; Julkunen H; Ammälä P; Teppo AM; Kurki P
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1333-4. PubMed ID: 1720280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target antigens of the SSA/Ro and SSB/La system.
    Ben-Chetrit E
    Am J Reprod Immunol; 1992; 28(3-4):256-8. PubMed ID: 1285896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.